Actively Recruiting
Study to Collect Blood Samples for Measuring Circulating Viral RNAs as Biomarkers in Hepatitis B Patients
Led by Hospices Civils de Lyon · Updated on 2026-05-22
3500
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are creating a group of patients with hepatitis B infection to collect biological samples and clinical data. This effort focuses on studying circulating viral RNAs as potential new markers for a functional cure of hepatitis B. The project is part of a larger program aimed at better understanding these viral components and their role in the disease. Participants will have blood samples taken during their regular medical follow-up visits. This observational study involves collecting these samples over a period of up to 46 months to analyze and quantify viral RNA as part of the research. There are no drug treatments or interventions being tested in this study. Participants will be involved in regular clinical visits where blood sampling occurs. Researchers will measure the number of biological samples collected to monitor progress. The study monitors patients over time without altering their medical care, and participation may last up to nearly four years.
CONDITIONS
Brief Title
Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.
Research Team
F
Fabien ZOULIM, Pr
M
Massimo LEVERO, Pr
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
